BPG is committed to discovery and dissemination of knowledge
Meta-Analysis
©The Author(s) 2025.
World J Gastroenterol. Dec 14, 2025; 31(46): 113608
Published online Dec 14, 2025. doi: 10.3748/wjg.v31.i46.113608
Figure 4
Figure 4 The metabolic dysfunction-associated steatotic liver disease prevalence map in China. A: Metabolic dysfunction-associated steatotic liver disease prevalence by region; B: Metabolic dysfunction-associated steatotic liver disease prevalence by province. MASLD: Metabolic dysfunction-associated steatotic liver disease; CI: Confidence interval.


Write to the Help Desk